A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome - PubMed (original) (raw)
A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
R S Legro et al. J Clin Endocrinol Metab. 1998 Aug.
Abstract
Women with polycystic ovary syndrome (PCOS) are profoundly insulin resistant, and the resultant hyperinsulinemia exacerbates the reproductive abnormalities of the syndrome. Agents that ameliorate insulin resistance and reduce circulating insulin levels could provide a new therapeutic modality for PCOS. Identifying the subset of PCOS women who are most insulin resistant may therefore be useful for selecting women who will respond to this therapy. We examined the correlation of basal and oral glucose-stimulated glucose and insulin levels and fasting and stimulated glucose/insulin (G:I) ratios with parameters of insulin sensitivity obtained by frequently sampled i.v. glucose tolerance test (FSIGT) to assess whether there is a simple screening test for insulin resistance in PCOS. Forty PCOS women (aged 18-40 yr; body mass index, >26 kg/m2) and 15 control women matched for age, weight, and ethnicity underwent both a 75-g oral glucose tolerance test (OGTT) and a FSIGT. The insulin sensitivity index (S(I)) was calculated by application of the minimal model of glucose kinetics to the dynamics of plasma glucose and insulin levels during the FSIGT. The best correlation in PCOS between S(I) and a fasting level was found with fasting G:I ratios (r = 0.73; P < 0.0001). A less substantial, but significant, correlation was found with fasting insulin levels (r = 0.50; P < 0.001), and no significant correlation was found with fasting glucose levels (r = 0.24; P = NS). The fasting G:I was more strongly correlated with S(I) than with integrated glucose and insulin responses during the OGTT. The only stronger correlation was with the OGTT 2 h G:I ratio (r = 0.74; P < 0.001). Stepwise regression analysis with S(I) as the dependent variable and fasting glucose and insulin levels, area under the curve for glucose and insulin, and a fasting G:I ratio showed that only the fasting G:I ratio was significantly predictive of S(I) in the model (F to remove value = 38.1; P < 0.001). When viewed as a screening test for insulin resistance in PCOS, setting a value of the fasting G:I ratio of less than 4.5 as abnormal (using an S(I) value below the 10th percentile of our control population as evidence for insulin resistance), the sensitivity of a fasting G:I ratio was 95%, the specificity was 84%, the positive predictive value was 87%, and the negative predictive value was 94%. Receiver operator curve analysis showed that this fasting G:I ratio was the single best screening measure for detecting insulin resistance. We conclude that a fasting G:I ratio may be useful as a screening test for insulin resistance in obese non-Hispanic white PCOS women. This may be a clinically useful parameter for selecting PCOS women most likely to respond to therapeutic interventions that improve insulin sensitivity.
Comment in
- Comment on glucose-to-insulin ratio as a measure of insulin sensitivity in women with PCOS. Polycystic ovary syndrome.
Nagasaka S, Ishikawa S, Saito T. Nagasaka S, et al. J Clin Endocrinol Metab. 1999 Jan;84(1):383. doi: 10.1210/jcem.84.1.5427-3. J Clin Endocrinol Metab. 1999. PMID: 9920114 No abstract available.
Similar articles
- Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M. Ducluzeau PH, et al. J Clin Endocrinol Metab. 2003 Aug;88(8):3626-31. doi: 10.1210/jc.2003-030219. J Clin Endocrinol Metab. 2003. PMID: 12915646 Clinical Trial. - Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z. Shi Y, et al. Neuro Endocrinol Lett. 2007 Dec;28(6):807-10. Neuro Endocrinol Lett. 2007. PMID: 18063948 - Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V, Nagamani M. Sepilian V, et al. J Soc Gynecol Investig. 2005 Feb;12(2):129-34. doi: 10.1016/j.jsgi.2004.09.003. J Soc Gynecol Investig. 2005. PMID: 15695109 - Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome.
Yildiz BO, Gedik O. Yildiz BO, et al. Reprod Biomed Online. 2004 Jun;8(6):649-56. doi: 10.1016/s1472-6483(10)61645-8. Reprod Biomed Online. 2004. PMID: 15169580 Review. - A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome.
Rezaee M, Asadi N, Pouralborz Y, Ghodrat M, Habibi S. Rezaee M, et al. J Pediatr Adolesc Gynecol. 2016 Dec;29(6):562-566. doi: 10.1016/j.jpag.2016.07.001. Epub 2016 Sep 1. J Pediatr Adolesc Gynecol. 2016. PMID: 27593259 Review.
Cited by
- A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis.
Pereira RR, Amladi ST, Varthakavi PK. Pereira RR, et al. Indian J Dermatol. 2011 Sep-Oct;56(5):520-6. doi: 10.4103/0019-5154.87144. Indian J Dermatol. 2011. PMID: 22121269 Free PMC article. - The Effect of Fasting Duration on Baseline Blood Glucose Concentration, Blood Insulin Concentration, Glucose/Insulin Ratio, Oral Sugar Test, and Insulin Response Test Results in Horses.
Bertin FR, Taylor SD, Bianco AW, Sojka-Kritchevsky JE. Bertin FR, et al. J Vet Intern Med. 2016 Sep;30(5):1726-1731. doi: 10.1111/jvim.14529. Epub 2016 Aug 2. J Vet Intern Med. 2016. PMID: 27481572 Free PMC article. Clinical Trial. - The ovarian androgen-producing cells: a 2001 perspective.
Magoffin DA. Magoffin DA. Rev Endocr Metab Disord. 2002 Jan;3(1):47-53. doi: 10.1023/a:1012700802220. Rev Endocr Metab Disord. 2002. PMID: 11883104 Review. No abstract available. - Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.
McDonnell T, Cussen L, McIlroy M, O'Reilly MW. McDonnell T, et al. Ther Adv Endocrinol Metab. 2022 Jul 18;13:20420188221113140. doi: 10.1177/20420188221113140. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35874313 Free PMC article. Review. - Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure.
Chang HR, Hsieh JC, Hsu BG, Wang LY, Chen MY, Wang JH. Chang HR, et al. PLoS One. 2013 Nov 12;8(11):e79096. doi: 10.1371/journal.pone.0079096. eCollection 2013. PLoS One. 2013. PMID: 24265747 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous